posted
Answer from the National Institute For Communicable Diseases. I asked if they could confirm this PR.
Maybe it's all true after all!!! wouldn't that be something !!!
Dear Mr. Xxxxx, yes I can confirm that the NICD evaluated the kit and the results are correct. The company should be able to provide you with a report that we provided to them for your scrutiny. The results however, are not necessarily unique to the kit and does not mean there is necessarily a competitive advantage against other kits.
Medical Services Completes Further Testing of Its VScan HIV Test Kit With Excellent Results
EDMONTON, Alberta, Dec. 27 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has completed additional testing of its VScan HIV test kit with the National Institute For Communicable Diseases. The regulatory agency tested 500 VScan HIV test kits with the following test results: Sensitivity- 100%, Specificity- 100%. It is very rare for a test kit to test with such accuracy. The final report also refers to ease of performance with a rating of 'very easy to use' and suitability for use rating as 'very suitable.' A report of this magnitude from an agency with the excellent reputation of the National Institute For Communicable Diseases confirms the reliability of the VScan HIV test kit.
This report once again demonstrates the accuracy of the VScan HIV test kit. The many excellent independent test results are now being included in new updated marketing brochures and will be included on the new website that is currently being constructed. It is felt that reports of this magnitude combined with additional approvals in more countries combined with the new website will significantly increase kit sales in 2007. The Company is looking forward to an exceptional new year.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
NOTE: Certain statements in this press release are 'forward-looking statements' within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
Dear Sir/Madam, I would be quite prepared to respond to your enquiry on the above but would like to better understand the nature of your enquiry.
Thank you,
Adrian Puren
Deputy Director
National Institute for Communicable Diseases
The views expressed in this email are, unless otherwise stated, those of the author and not those of the National Health Laboratory Services or its management. The information in this e-mail is confidential and is intended solely for the addressee. Access to this e-mail by anyone else is unauthorized. If you are not the intended recipient, any disclosure, copying, distribution or any action taken or omitted in reliance on this, is prohibited and may be unlawful. Whilst all reasonable steps are taken to ensure the accuracy and integrity of information and data transmitted electronically and to preserve the confidentiality thereof, no liability or responsibility whatsoever is accepted if information or data is, for whatever reason, corrupted or does not reach its intended destination.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
